1. DIGITAL.CSIC
  2. Biología y Biomedicina
  3. Instituto de Biología Molecular y Celular del Cáncer de Salamanca (IBMCC)
  4. (IBMCC) Artículos
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/59189
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE

Comparte tu historia
de Acceso Abierto
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Campo DC Valor Lengua/Idioma
dc.contributor.authorOrdóñez, José Luis-
dc.contributor.authorOsuna, Daniel-
dc.contributor.authorHerrero-Martín, David-
dc.contributor.authorÁlava, Enrique de-
dc.contributor.authorMadoz-Gúrpide, Juan-
dc.date.accessioned2012-10-30T11:32:28Z-
dc.date.available2012-10-30T11:32:28Z-
dc.date.issued2009-
dc.identifierdoi: 10.1158/0008-5472.CAN-08-4041-
dc.identifierissn: 0008-5472-
dc.identifiere-issn: 1538-7445-
dc.identifier.citationCancer Research 69(18): 7140-7150 (2009)-
dc.identifier.urihttp://hdl.handle.net/10261/59189-
dc.description.abstractEwing's sarcoma family tumors (EFT) are characterized by specific chromosomal translocations, which lead to EWS/ETS transcription factors.Elucidation of EWS/ETS target gene networks within the context of other signaling pathways, together with the identification of the initiating cell, and the development of genetically engineered mice will hopefully lead to biology-based therapeutic strategies for these tumors. 2009 American Association for Cancer Research.-
dc.description.sponsorshipGrant support: The Centro de Investigación del Cáncer participates in EuroBoNeT, the European research network on bone tumors (FP6-2004-Lifescihealth-5, proposal number 018814)-European Commission. The Laboratory of Molecular Pathology of Sarcomas is also supported by the Spanish Ministry of Science and Innovation (FIS-FEDER, PI081828)and by the Junta de Castilla y León (SAN 673/SA 37/08). J. L. Ordóñez is supported by ISCIII (Contratos Perfeccionamiento CD6/00001); D. Osuna is supported by EuroBoNeT; J. Madoz-Gúrpide is supported by the Spanish Ministry of Science and Innovation, Ramón y Cajal Program.-
dc.language.isoeng-
dc.publisherAmerican Association for Cancer Research-
dc.rightsclosedAccess-
dc.titleAdvances in Ewing's sarcoma research: Where are we now and what lies ahead?-
dc.typeartículo-
dc.identifier.doi10.1158/0008-5472.CAN-08-4041-
dc.date.updated2012-10-30T11:32:29Z-
dc.description.versionPeer Reviewed-
dc.type.coarhttp://purl.org/coar/resource_type/c_6501es_ES
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeartículo-
item.cerifentitytypePublications-
item.grantfulltextnone-
Aparece en las colecciones: (IBMCC) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Show simple item record

CORE Recommender

SCOPUSTM   
Citations

108
checked on 17-abr-2024

WEB OF SCIENCETM
Citations

80
checked on 24-feb-2024

Page view(s)

286
checked on 23-abr-2024

Download(s)

93
checked on 23-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.